AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Curis Inc Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Curis, Inc. filed a prospectus supplement under its existing shelf registration to offer and sell up to $8,137,047 of its common stock through an Amended and Restated Sales Agreement with Cantor Fitzgerald & Co. and JonesTrading Institutional Services LLC acting as agents. The Shares are registered under the companys Registration Statement and will be offered only by means of the Prospectus Supplement.

The company notified the agents that it terminated a prior prospectus related to an offering of up to $100.0 million, while confirming the Sales Agreement remains in full force and effect. Wilmer Cutler Pickering Hale and Dorr LLP provided a legal opinion and consent included as exhibits. This filing documents terms for a potential equity offering and the related legal opinions; it does not itself constitute a sale of securities.

Curis, Inc. ha depositato un supplemento al prospetto nell'ambito della sua registrazione a scaglione esistente per offrire e vendere fino a $8,137,047 di azioni ordinarie tramite un Contratto di Vendita modificato e riformulato con Cantor Fitzgerald & Co. e JonesTrading Institutional Services LLC in qualità di agenti. Le azioni sono registrate nella Dichiarazione di Registrazione della società e saranno offerte esclusivamente mediante il Supplemento al Prospetto.

La società ha informato gli agenti di aver annullato un prospetto precedente relativo a un'offerta fino a $100.0 milioni, confermando però che il Contratto di Vendita resta pienamente valido. Wilmer Cutler Pickering Hale and Dorr LLP ha fornito un parere legale e il relativo consenso, inclusi come allegati. Questa comunicazione documenta i termini di una possibile offerta di capitale e i pareri legali connessi; non costituisce di per sé una vendita di titoli.

Curis, Inc. presentó un suplemento al prospecto en el marco de su registro en blanco vigente para ofrecer y vender hasta $8,137,047 de sus acciones ordinarias mediante un Acuerdo de Venta Enmendado y Restablecido con Cantor Fitzgerald & Co. y JonesTrading Institutional Services LLC como agentes. Las acciones están registradas en la Declaración de Registro de la compañía y se ofrecerán únicamente a través del Suplemento al Prospecto.

La compañía notificó a los agentes que canceló un prospecto anterior relacionado con una oferta de hasta $100.0 millones, al tiempo que confirmó que el Acuerdo de Venta sigue en pleno vigor. Wilmer Cutler Pickering Hale and Dorr LLP proporcionó una opinión legal y su consentimiento, incluidos como anexos. Esta presentación documenta los términos de una posible oferta de capital y las opiniones legales relacionadas; no constituye por sí misma la venta de valores.

Curis, Inc.ëŠ� 기존ì� 쉘프 등ë¡í•˜ì— ë³´ì¶©ë� ì¦ê¶Œíˆ¬ìžì„¤ëª…서를 제출하여 Cantor Fitzgerald & Co. ë°� JonesTrading Institutional Services LLCë¥� 대리ì¸ìœ¼ë¡œ 하는 ìˆ˜ì •Â·ìž¬ìž‘ì„±ëœ íŒë§¤ê³„약ì� 통해 최대 $8,137,047 ìƒë‹¹ì� 보통주를 제공·íŒë§¤í•œë‹¤ê³� ë°í˜”습니ë‹�. 해당 주ì‹ì€ 회사ì� 등ë¡ëª…ì„¸ì„œì— ë“±ë¡ë˜ì–´ 있으ë©�, ì˜¤ì§ ë³´ì¶©ë� 투ìžì„¤ëª…서를 통해서만 제공ë©ë‹ˆë‹�.

회사ëŠ� ì´ì „ì—� 최대 $100.0 millionì—� 해당하는 공모와 ê´€ë ¨ëœ ê¸°ì¡´ 투ìžì„¤ëª…서를 종료했다ê³� 대리ì¸ë“¤ì—ê²� 통지했으ë©�, ë™ì‹œì—� íŒë§¤ê³„ì•½ì€ ì—¬ì „íž� 유효하다ê³� 확ì¸í–ˆìŠµë‹ˆë‹¤. Wilmer Cutler Pickering Hale and Dorr LLPëŠ� ë²•ì  ì˜ê²¬ì„œì™€ ë™ì˜ë¥� 제출서류ë¡� 제공했습니다. ì� 제출서는 잠재ì � ìžë³¸ê³µëª¨ì� ì¡°ê±´ê³� ê´€ë � ë²•ì  ì˜ê²¬ì� 문서화한 것으ë¡�, ê·� ìžì²´ë¡� ì¦ê¶Œì� íŒë§¤ë¥� ì˜ë¯¸í•˜ì§€ëŠ� 않습니다.

Curis, Inc. a déposé un supplément au prospectus dans le cadre de son enregistrement sur étagère existant afin d'offrir et de vendre jusqu'à $8,137,047 de ses actions ordinaires dans le cadre d'un accord de vente modifié et refondu avec Cantor Fitzgerald & Co. et JonesTrading Institutional Services LLC agissant comme agents. Les actions sont inscrites dans la Déclaration d'Enregistrement de la société et ne seront offertes que par le biais du Supplément au Prospectus.

La société a informé les agents qu'elle avait mis fin à un prospectus antérieur relatif à une offre allant jusqu'à $100.0 million, tout en confirmant que l'Accord de Vente demeure pleinement en vigueur. Wilmer Cutler Pickering Hale and Dorr LLP a fourni un avis juridique et son consentement, inclus en pièces jointes. Ce dépôt documente les modalités d'une éventuelle offre en capital et les avis juridiques associés ; il ne constitue pas en lui‑même une vente de titres.

Curis, Inc. hat im Rahmen ihrer bestehenden Shelf-Registrierung einen Nachtrag zum Prospekt eingereicht, um über eine geänderte und neu gefasste Verkaufsvereinbarung mit Cantor Fitzgerald & Co. und JonesTrading Institutional Services LLC als Agenten bis zu $8,137,047 ihrer Stammaktien anzubieten und zu verkaufen. Die Aktien sind in der Registrierungs­erklärung des Unternehmens eingetragen und werden ausschließlich mittels dieses Prospektnachtrags angeboten.

Das Unternehmen teilte den Agenten mit, dass es einen früheren Prospekt im Zusammenhang mit einem Angebot von bis zu $100.0 Millionen aufgehoben habe, bestätigte jedoch zugleich, dass die Verkaufsvereinbarung weiterhin in vollem Umfang gilt. Wilmer Cutler Pickering Hale and Dorr LLP stellte ein Rechtsgutachten und seine Zustimmung als Anlagen zur Verfügung. Diese Einreichung dokumentiert die Konditionen eines möglichen Kapitalangebots und die zugehörigen Rechtsgutachten; sie stellt jedoch keine eigenständige Wertpapierveräußerung dar.

Positive
  • Registered offering of up to $8,137,047 of common stock provides a defined mechanism to raise capital
  • Sales Agreement remains in full force, preserving the companys ability to sell shares through Cantor Fitzgerald and JonesTrading
  • Legal opinion and consent from Wilmer Cutler Pickering Hale and Dorr LLP are included as exhibits
Negative
  • Prior prospectus related to an offering of up to $100.0 million was terminated, reducing the previously disclosed potential offering size
  • Current prospectus supplement is limited to $8,137,047, a substantially smaller registered amount than the prior prospectus

Insights

TL;DR Registered a targeted equity sale for $8.14M while terminating a prior $100M prospectus; routine financing action, neutral near term.

The prospectus supplement explicitly registers up to $8,137,047 of common stock for issuance under the existing Amended and Restated Sales Agreement with Cantor and JonesTrading. The filing confirms the Sales Agreement remains active despite termination of a prior prospectus tied to a $100.0 million potential offering. From a capital markets perspective, this creates a defined, limited avenue for immediate issuance rather than a broad $100M shelf; the document focuses on registration mechanics and legal clearance rather than executed financings.

TL;DR Filing documents legal and procedural steps for a capped share offering and includes counsels opinion and consent.

The inclusion of an opinion and consent from Wilmer Cutler Pickering Hale and Dorr LLP (Exhibit 5.1 and 23.1) indicates standard legal clearance for the registered Shares. The exhibit structure and the statement that offerings will be made only by means of the Prospectus Supplement reflect routine governance and disclosure procedures for equity issuance. Termination of the prior prospectus related to a $100.0 million potential offering is a notable procedural change recorded in this report.

Curis, Inc. ha depositato un supplemento al prospetto nell'ambito della sua registrazione a scaglione esistente per offrire e vendere fino a $8,137,047 di azioni ordinarie tramite un Contratto di Vendita modificato e riformulato con Cantor Fitzgerald & Co. e JonesTrading Institutional Services LLC in qualità di agenti. Le azioni sono registrate nella Dichiarazione di Registrazione della società e saranno offerte esclusivamente mediante il Supplemento al Prospetto.

La società ha informato gli agenti di aver annullato un prospetto precedente relativo a un'offerta fino a $100.0 milioni, confermando però che il Contratto di Vendita resta pienamente valido. Wilmer Cutler Pickering Hale and Dorr LLP ha fornito un parere legale e il relativo consenso, inclusi come allegati. Questa comunicazione documenta i termini di una possibile offerta di capitale e i pareri legali connessi; non costituisce di per sé una vendita di titoli.

Curis, Inc. presentó un suplemento al prospecto en el marco de su registro en blanco vigente para ofrecer y vender hasta $8,137,047 de sus acciones ordinarias mediante un Acuerdo de Venta Enmendado y Restablecido con Cantor Fitzgerald & Co. y JonesTrading Institutional Services LLC como agentes. Las acciones están registradas en la Declaración de Registro de la compañía y se ofrecerán únicamente a través del Suplemento al Prospecto.

La compañía notificó a los agentes que canceló un prospecto anterior relacionado con una oferta de hasta $100.0 millones, al tiempo que confirmó que el Acuerdo de Venta sigue en pleno vigor. Wilmer Cutler Pickering Hale and Dorr LLP proporcionó una opinión legal y su consentimiento, incluidos como anexos. Esta presentación documenta los términos de una posible oferta de capital y las opiniones legales relacionadas; no constituye por sí misma la venta de valores.

Curis, Inc.ëŠ� 기존ì� 쉘프 등ë¡í•˜ì— ë³´ì¶©ë� ì¦ê¶Œíˆ¬ìžì„¤ëª…서를 제출하여 Cantor Fitzgerald & Co. ë°� JonesTrading Institutional Services LLCë¥� 대리ì¸ìœ¼ë¡œ 하는 ìˆ˜ì •Â·ìž¬ìž‘ì„±ëœ íŒë§¤ê³„약ì� 통해 최대 $8,137,047 ìƒë‹¹ì� 보통주를 제공·íŒë§¤í•œë‹¤ê³� ë°í˜”습니ë‹�. 해당 주ì‹ì€ 회사ì� 등ë¡ëª…ì„¸ì„œì— ë“±ë¡ë˜ì–´ 있으ë©�, ì˜¤ì§ ë³´ì¶©ë� 투ìžì„¤ëª…서를 통해서만 제공ë©ë‹ˆë‹�.

회사ëŠ� ì´ì „ì—� 최대 $100.0 millionì—� 해당하는 공모와 ê´€ë ¨ëœ ê¸°ì¡´ 투ìžì„¤ëª…서를 종료했다ê³� 대리ì¸ë“¤ì—ê²� 통지했으ë©�, ë™ì‹œì—� íŒë§¤ê³„ì•½ì€ ì—¬ì „íž� 유효하다ê³� 확ì¸í–ˆìŠµë‹ˆë‹¤. Wilmer Cutler Pickering Hale and Dorr LLPëŠ� ë²•ì  ì˜ê²¬ì„œì™€ ë™ì˜ë¥� 제출서류ë¡� 제공했습니다. ì� 제출서는 잠재ì � ìžë³¸ê³µëª¨ì� ì¡°ê±´ê³� ê´€ë � ë²•ì  ì˜ê²¬ì� 문서화한 것으ë¡�, ê·� ìžì²´ë¡� ì¦ê¶Œì� íŒë§¤ë¥� ì˜ë¯¸í•˜ì§€ëŠ� 않습니다.

Curis, Inc. a déposé un supplément au prospectus dans le cadre de son enregistrement sur étagère existant afin d'offrir et de vendre jusqu'à $8,137,047 de ses actions ordinaires dans le cadre d'un accord de vente modifié et refondu avec Cantor Fitzgerald & Co. et JonesTrading Institutional Services LLC agissant comme agents. Les actions sont inscrites dans la Déclaration d'Enregistrement de la société et ne seront offertes que par le biais du Supplément au Prospectus.

La société a informé les agents qu'elle avait mis fin à un prospectus antérieur relatif à une offre allant jusqu'à $100.0 million, tout en confirmant que l'Accord de Vente demeure pleinement en vigueur. Wilmer Cutler Pickering Hale and Dorr LLP a fourni un avis juridique et son consentement, inclus en pièces jointes. Ce dépôt documente les modalités d'une éventuelle offre en capital et les avis juridiques associés ; il ne constitue pas en lui‑même une vente de titres.

Curis, Inc. hat im Rahmen ihrer bestehenden Shelf-Registrierung einen Nachtrag zum Prospekt eingereicht, um über eine geänderte und neu gefasste Verkaufsvereinbarung mit Cantor Fitzgerald & Co. und JonesTrading Institutional Services LLC als Agenten bis zu $8,137,047 ihrer Stammaktien anzubieten und zu verkaufen. Die Aktien sind in der Registrierungs­erklärung des Unternehmens eingetragen und werden ausschließlich mittels dieses Prospektnachtrags angeboten.

Das Unternehmen teilte den Agenten mit, dass es einen früheren Prospekt im Zusammenhang mit einem Angebot von bis zu $100.0 Millionen aufgehoben habe, bestätigte jedoch zugleich, dass die Verkaufsvereinbarung weiterhin in vollem Umfang gilt. Wilmer Cutler Pickering Hale and Dorr LLP stellte ein Rechtsgutachten und seine Zustimmung als Anlagen zur Verfügung. Diese Einreichung dokumentiert die Konditionen eines möglichen Kapitalangebots und die zugehörigen Rechtsgutachten; sie stellt jedoch keine eigenständige Wertpapierveräußerung dar.

0001108205false00011082052025-08-082025-08-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 

_____________________
FORM 8-K

_____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event Reported): August 8, 2025
Curis, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware000-3034704-3505116
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
128 Spring Street, Building C - Suite 500, Lexington, MA 02421
(Address of Principal Executive Offices) (Zip Code)
(617) 503-6500
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:        
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.01 per shareCRIS
Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company  



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 8.01. Other Events.
On August 8, 2025, Curis, Inc. (the “Company”) filed a prospectus supplement (the “Prospectus Supplement”) under the Company’s universal shelf registration statement on Form S-3 (File No. 333-276950) that was originally filed with the Securities and Exchange Commission (the “SEC”) on February 8, 2024 and was declared effective by the SEC on April 12, 2024 (the “Registration Statement”), relating to the offer and sale of a total of up to $8,137,047 of shares of the Company’s common stock, par value $0.01 per share (the “Shares”), pursuant to an Amended and Restated Sales Agreement, dated February 8, 2024, between the Company and Cantor Fitzgerald & Co. (“Cantor”) and JonesTrading Institutional Services LLC (“Jones”), as agents (the “Sales Agreement”).
As previously disclosed, on July 1, 2025, the Company notified Cantor and Jones that it was terminating a prior prospectus filed with the SEC on February 8, 2024 and dated April 12, 2024 related to the offer and sale of shares of the Company’s common stock having an aggregate offering price of up to $100.0 million pursuant to the Sales Agreement. The Sales Agreement remained in full force and effect.
Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Company, has issued a legal opinion relating to the Shares. A copy of such legal opinion, including the consent included therein, is attached as Exhibit 5.1 hereto.
The Shares are registered pursuant to the Registration Statement and the base prospectus contained therein, and offerings for the Shares will be made only by means of the Prospectus Supplement. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.



Item 9.01. Financial Statements and Exhibits.
Exhibit Number Description
5.1
Opinion of Wilmer Cutler Pickering Hale and Dorr LLP
23.1
Consent of Wilmer Cutler Pickering Hale and Dorr LLP (contained in Exhibit 5.1 above)
104Cover Page Interactive Data File (embedded within the InLine XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 Curis, Inc.
   
  
Date:August 8, 2025By: /s/ Diantha Duvall
  Diantha Duvall
  Chief Financial Officer
  

FAQ

What did Curis (CRIS) file in this 8-K?

Curis filed a prospectus supplement under its shelf registration to offer and sell up to $8,137,047 of common stock pursuant to an Amended and Restated Sales Agreement with Cantor Fitzgerald & Co. and JonesTrading Institutional Services LLC.

How much equity is being registered for potential sale?

The prospectus supplement registers up to $8,137,047 of the companys common stock.

Did Curis cancel any previous offering authority?

Yes. The company notified its agents that it terminated a prior prospectus related to an offering of up to $100.0 million.

Who are the agents under the Sales Agreement?

The agents named are Cantor Fitzgerald & Co. and JonesTrading Institutional Services LLC.

Are the Shares registered and is there legal counsel sign-off?

Yes. The Shares are registered pursuant to the Registration Statement and Wilmer Cutler Pickering Hale and Dorr LLP provided a legal opinion and consent included as exhibits.

Does this 8-K itself sell any shares?

No. The filing states it does not constitute an offer to sell or the solicitation of an offer to buy securities; offerings will be made only by means of the Prospectus Supplement.
Curis

NASDAQ:CRIS

CRIS Rankings

CRIS Latest News

CRIS Latest SEC Filings

CRIS Stock Data

20.87M
11.59M
7.23%
34.32%
1.6%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
LEXINGTON